Known metabolic connections between ATP and the downstream metabolite ADO suggested that changes to ATP levels shown in Figure 4A would be reflected in changes to ADO, an important modulator of PD-related endpoints via adenosine receptors. Here, ADO is linked to Parkinson disease.